The Recall Desk
HighFDA (Drugs)·D-0269-2026·Announced 2026-01-21

EXCEDRIN Pain Reliever Recalled Due to Rodent Exposure in Distribution Center

EXCEDRIN 2'S DISP.- 30 CT is recalled nationwide due to CGMP deviations, insanitary conditions, and rodent exposure at the Gold Star Distribution distribution center.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II recall involving potential contamination from rodent exposure in a medication distribution center. While no illnesses have been reported, medications are risk-of-harm products, and rodent contamination poses a potential health risk.

Plain-English summary

Gold Star Distribution Inc is recalling EXCEDRIN 2'S DISP.- 30 CT nationwide. The recall stems from Current Good Manufacturing Practice (CGMP) deviations identified at the company's distribution center.

The FDA identified insanitary conditions and rodent exposure/activity at the facility. These conditions present a potential contamination risk to the product.

All unexpired lots distributed by Gold Star Distribution are included in this recall. The product was distributed nationwide in the United States.

Consumers should discontinue use of this product. For information regarding this recall or product disposal, contact Gold Star Distribution Inc or the FDA.

The recalled product

Product
EXCEDRIN 2'S DISP.- 30 CT
Manufacturer
GOLD STAR DISTRIBUTION INC
Category
Drug
Hazard
  • cgmp-deviation
  • insanitary-conditions
  • rodent-contamination

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry distributed by Gold Star Distribution.

Distribution

Distributed nationwide across the United States.

Related recalls

Same category